First human tests begin for new drug candidate
NCT ID NCT06868082
Summary
This early-stage study tested the safety and how the body processes two different versions of an experimental drug called solrikitug. Researchers gave the drug to 32 healthy Japanese and non-Japanese volunteers to check for side effects and measure drug levels in the blood. The main goal was to gather basic safety information before testing in people with specific medical conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Brisbane, Queensland, Australia
Conditions
Explore the condition pages connected to this study.